BSEAGM/EGM10 Aug 2026 · 10 Aug 2026, 04:55 pm
Scrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
Bal Pharma Ltd · 524824
✦ AI SummaryResults
Bal Pharma Ltd's scrutinizer's report on postal ballot voting has been submitted, with no rejections or modifications received from shareholders after the issuance of a corrigendum. The voting process was conducted electronically, and the results will be considered as the final voting.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Attachments (1)
📄pdf
Download →
564e344f-2a52-4997-a800-9486d3b07702.pdf
View document text
To To Date: August 10, 2026
Listing Compliance Department BSE Limited
National Stock Exchange of India Limited, 1st Floor, New Trading Ring,
Exchange Plaza, 5th Floor, Plot No. C/2, G Block, Rotunda Building, P.J. Towers,
Bandra Kurla Complex, Bandra (E), Dalal Street,
Mumbai-400051 Mumbai – 400001
Symbol: BALPHARMA Scrip Code: 524824
Sub: Scrutinizer's Report on the result of the Postal Ballot Voting (remote e-voting).
Dear Sir/Madam,
With reference to our earlier intimation dated July 09, 2026 regarding the Postal Ballot Notice of
the Company, read together with its Corrigendum dated July 23, 2026, and pursuant to Regulation
44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, Mr. Parameshwar Bhat, Practicing Company Secretary
(M. No.11004) Bangalore, was appointed as the scrutinizer of poll for conducting the postal ballot
process and has submitted his report on Monday 10th August 2026.
Scrutinizer's Report on the result of the Postal Ballot received from shareholders only through the
electronic voting process (remote e-voting) is enclosed along with the register showing the
particulars of the e-votes registered on the National Securities Depository Limited ('NSDL')
e-voting system in respect of the said Resolutions.
The aforesaid documents are also being made available on the website of the Company.
You are requested to kindly take the same on your records
Thanking You.
For Bal Pharma Ltd
Shreepada ML
Company Secretary and Compliance officer
ICSI M No : A66681
Enclosure: As above
PARAMESHWAR G. BHAT # 496/4, II Floor, 10th Cross
B.Com., LLB, ML, MBA, FCS Near Bashyam Circle, Sadashivanagar,
Bangalore - 560 080
Company Secretary Tel : +91 80 23610847
Telefax ; +91 80 41231106
e-mail : parameshwar@vjkt.in
parameshwar.g.bhat@gmail.com
REPORT OF SCRUTINIZER ON E-VOTING AND POSTAL BALLOT PROCESS
Private & Confidential
{Strictly to the addressee only}
10 August, 2026
Mr. ShaileshSiroya
Managing Director
Bal Pharma Limited
(CIN: L85110KA1987PLC008368)
21 & 22, Bommasandra Industrial Area,
Bommasandra Industrial Estate,
Bengaluru- 560099, Karnataka, India
Dear Sir,
|, Parameshwar G. Bhat, Company Secretary in Whole-Time Practice (FCS No 8860,
CP No.11004), having Office at # 496/4, 2™ Floor, 10" Cross, Near Bashyam Circle,
Sadashivanagar, Bengaluru — 560080, was duly appointed as Scrutinizer by the
Company for the purpose of scrutinizing the Postal Ballot undertaken by your
Company vide Notice dated 9'" July,2026, facility provided as per Sections 108 and
110 of the Companies Act, 2013 (‘the Act’), read with Rules 20 and 22 of the
Companies (Management and Administration) Rules, 2014 as amended from time to
time (‘the Rules’) and various circulars issued by the Ministry of Corporate Affairs
(MCA) namely, Circular No.19/2021 dated December 8, 2021 read with Circular
No.14/2020 dated April 8, 2020, Circular No.17/2020 dated April 13, 2020, Circular No.
20/2020 dated May 5, 2020, Circular No. 02/2021 dated January 13, 2021, Circular
No. 03/2022 dated May 5, 2022, General Circular No. 11/2022 dated December 28,
2022, General Circular No. 09/2024 dated September 19, 2024 and read with other
relevant circulars issued in this regard the latest being General Circular No. 03/2025
dated September 22, 2025 (collectively referred to as "MCA Circulars") and the
provisions of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
My responsibility as Scrutinizer is to ensure that the voting process is conducted in a
fair and transparent manner and is restricted to make a Scrutinizer’s Report for the
votes cast in “favour” or “against” on the resolution proposed in the Notice dated 9"
July, 2026based on the report provided by National Securities Depository Limited
(NSDL), the Agency engaged by the Company to provide e-voting facility up to 8"
August, 2026 (5.00 P.M. IST).
Further, the Company issued a Corrigendum dated 23™ July, 2026to the Notice dated
9g" July, 2026 (Original Notice), which shall form an integral part of the Original Notice
and the Explanatory Statement annexed thereto and shall be read in conjunction with
the Original Notice. The Company informed all the members of the Company that the
members who have already cast their votes in the ongoing Postal Ballot i.e. after the
start of e-Voting but prior to receiving this Corrigendum to the Original Notice, and if
they wish to modify their votes in light of the information provided in the Corrigendum,
they can do so by writing an email to the scrutinizer at the following email address
parameshwar@vijkt.inwith a copy marked to evoting@nsdl.comon or before 05.00 P.M.
(IST) on Saturday, August 8, 2026.
In terms of the aforesaid Original Notice read with Corrigendum and as per the
provisions of the Act and the Rules, e-voting was kept open from Friday, 10" July,
2026 (9.00 A.M IST) till Saturday,8"" August, 2026 (5.00 P.M IST) and Members were
requested to cast their votes electronically conveying their assent or dissent in respect
of the Resolution on the e-voting platform.
| was not in receipt of rejection/modification/comments from any member(s), post
issuance of the Corrigendum dated 23% July, 2026 till 8'" August, 2026 (5.00 P.M.
IST). As per the information received from the Company/NSDL, neither the Company
nor the National Securities Depository Limited (NSDL) on evoting@nsdl.com, were in
receipt of any rejection/modification/comments from any member(s), post issuance of
the Corrigendum dated 23" July, 2026 till 8" August, 2026 (5.00 P.M. IST). Hence, the
votes casted by the Members as per the report generated from the e-voting website of
National Securities Depository Limited (NSDL) was considered as the final voting.
The details containing inter-alia, the list of the Members, who voted “for” or “against”
on the Resolution that was put to vote, was derived from the report generated from the
e-voting website of National Securities Depository Limited (NSDL) ie.
https://evoting.nsdl.com and based on such reports,
a. 99 (Ninety Nine) members (folio wise) have cast their votes through remote e-
voting.
On verification of 99 (Ninety Nine) members voting through e-Voting, up to 8"" August,
2026 (5.00 P.M IST)from the Shareholders of Bal Pharma Limi patding Equity
Shares and based on the information made available to me, | hereby submit my
Report on the results of the Postal Ballot, as follows:
VOTING ANALYSIS:
SPECIAL BUSINESS:
ITEM NO. 1._To consider the issue of 10,00,000 Warrants to the Promoter of the
company on preferential basis.
SPECIAL RESOLUTION:
Particulars No. of votes contained in Remote E-voting
No. of members No. of Votes cast % Total Valid Votes
voted (Shares) Cast
Assent 86 8155799 99.96
Dissent 13 3264 0.04
Total 99 8159063 100.00
Invalid / NIL NA NA
Abstained
Based on the above information, you may kindly declare the results and take steps
accordingly.
Thanking you
Yours faithfully
Practicing Company Secretary
Membership No.: 8860
CP No.: 11004
Scrutinizer
Peer Review No.:5508/2024
UDIN: F008860H001062748